Procurement Summary
Country : USA
Summary : Synthesis of ‘960 for Ncats Etb
Deadline : 09 Aug 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 105237377
Document Ref. No. : 75N95024R00111
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Description
(i) This is a Small Business non-competitive combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.
(ii) The solicitation number is 75N95024R00111 and the solicitation is issued as a request for quotation (RFQ).
This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures; and FAR Part 12—Acquisition of Commercial Items, and is not expected to exceed the simplified acquisition threshold.
THIS IS A NON-COMPETITIVE (NOTICE OF INTENT) COMBINED SYNOPSIS SOLICITATION TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME).
The National Institute on Drug Abuse (NIDA), Office of Acquisition (OA), on behalf of The National Center for Advancing Translational Sciences (NCATS), Division of Preclinical Innovation (DPI) intends to negotiate and award a Firm Fixed Priced contract without providing for full and open competition to Cell Mosaic, 10A Roessler Road, Woburn, MA 01801 for synthesis and delivery of 100g the lead NNMT inhibitor '960 after 6-step synthesis for animal studies.
This acquisition is conducted as non-competitive for a commercial item or service and is conducted pursuant to FAR 13.106-1(b)(1).
Only this suggested source can furnish the requirements, to the exclusion of other sources, because the project entails the synthesis of the key inhibitor ‘960. The synthesis has six steps. The contractor has prior experience in the scale up synthesis of the third intermediate which is a chiral material and thus has the ability to carry out the first three steps in 50 g scale; this will ensure significant cost savings fo...
Active Contract Opportunity Notice ID 75N95024R00111 Related Notice Department/Ind. Agency HEALTH AND HUMAN SERVICES, DEPARTMENT OF Sub-tier NATIONAL INSTITUTES OF HEALTH Office NATIONAL INSTITUTES OF HEALTH NCATS
General Information
Contract Opportunity Type: Combined Synopsis/Solicitation (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Aug 02, 2024 02:57 pm EDT
Original Date Offers Due: Aug 09, 2024 02:00 pm EDT
Inactive Policy: 15 days after date offers due
Original Inactive Date: Aug 24, 2024
Initiative: None
Classification
Original Set Aside: Total Small Business Set-Aside (FAR 19.5)
Product Service Code: Q301 - REFERENCE LABORATORY TESTING
NAICS Code: 325998 - All Other Miscellaneous Chemical Product and Preparation Manufacturing
Place of Performance: Rockville, MD USA
Documents
Tender Notice
Attachment-1--SOW.pdf
Attachment-2--FAR-52.212-4-Addendum.pdf
Attachment-3--FAR-52.212-5-FILLABLE-May-2024_Final.pdf
Attachment-4--Invoicing-Instructions-With-IPP-3-23-NIDA-OA.pdf
Attachment-5--FAR-52.204-24-Nov-2021.pdf
Attachment-6--FAR-52.204-26-Oct-2020.pdf